Access to Cutting Edge Imaging Technologies in Europe

Imaging techniques from microscopy to computer tomography are key tools for all life scientists to understand living systems. The availability of cutting edge imaging technologies is becoming a critical factor for success in science and human health care, but access to advanced technology expertise in imaging is often limited. Euro-BioImaging, a project on the roadmap of the European Strategy Forum on Research Infrastructures (ESFRI), aims to provide scientists throughout Europe with open access to state-of-the-art imaging technologies at all levels of biological and biomedical research, from bench to bedside. On December 1st 2010 the project started with an initial 3-year preparatory phase, which is funded under the 7th Framework Programme of the European Union.

"The coordinated and harmonised deployment of imaging infrastructure under the Euro-BioImaging umbrella significantly addresses the fragmentation of such efforts currently present in Europe and will facilitate the translation from basic results to medical applications," says Stefan Schönberg from the European Institute for Biomedical Imaging Research (EIBIR), scientific coordinator for medical imaging, who is based at the Medical Faculty Mannheim.

In its preparatory phase Euro-BioImaging will develop a plan to construct and operate a set of complementary and strongly interlinked imaging infrastructure facilities. This plan will be based on a comprehensive assessment of researchers' needs in terms of access, service, and training. Euro-BioImaging will also establish the legal, governmental and financial framework for such infrastructures, and seek agreements with funding bodies. Eligibility criteria for participating facilities will be defined, an independent evaluation panel will be established, and a call for applications will be announced.

"Euro-BioImaging will support research, training and innovation in biological and biomedical imaging on a pan-European level, and provide a clear path of access to imaging technologies for every biomedical scientist in Europe," says Jan Ellenberg from the European Molecular Biology Laboratory (EMBL), scientific coordinator for biological imaging.

At the kick-off meeting on January 17th 2011 Euro-BioImaging has assembled its 39 core partners to set the course for a successful accomplishment of the first year's project goals. The focus will be on the consultation with stakeholders and the evaluation of European researchers' demands for imaging infrastructure.

For further information, please visit:
http://www.eurobioimaging.eu

About Euro-BioImaging
Euro-BioImaging is one of 10 Biological and Medical Sciences Projects included in the roadmap of the European Strategy Forum on Research Infrastructures (ESFRI). It is scientifically coordinated by the European Institute for Biomedical Imaging Research, EIBIR (Medical Imaging) and the European Molecular Biology Laboratory, EMBL (Biological Imaging).

The Euro-BioImaging Preparatory Phase consortium comprises 39 core partners and more than 180 associate partner institutions from 24 countries. The broad interest in this research infrastructure even at an early stage of the project clearly indicates the pan-European support for the vision of Euro-BioImaging.

About EIBIR
The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit limited liability company that was founded in 2006 by the European Society of Radiology (ESR), dedicated to the co-ordination of research. EIBIR has the aim of co-ordinating and supporting the development of biomedical imaging technologies and the dissemination of knowledge with the ultimate goal of improving diagnosis, treatment and prevention of disease. The platform supports networking activities in research and is key to spreading good practice, promoting common initiatives and interoperability in the field of biomedical imaging research. This will generate critical mass and help coordinate research into new instrumentation, new methods, concepts and technologies. EIBIR currently has over 280 member institutions, two thirds of which are made up by clinical departments and one third by basic science laboratories. EIBIR has six shareholder organisations in addition to ESR: CIRSE; ESMRMB, EANM, EFOMP, COCIR, and EORTC.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...